Jazz Pharmaceuticals (JAZZ) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist

123.450
+1.810+1.49%

Close Dec 4 16:00 ET

123.450
0.0000.00%

Post 16:20 ET

7.46BMarket Cap17.49P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Jazz Pharmaceuticals Announces Ziihera (Zanidatamab-hrii) Investor Webcast on December 11, 2024
PR Newswire16:15 ET
Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual Meeting
PR NewswireDec 3 07:49 ET
Jazz Pharmaceuticals (JAZZ) Is Making Sweet Music With a Diverse Portfolio
TipRanksDec 1 04:43 ET
Why Jazz Pharmaceuticals (JAZZ) Is One of the Most Undervalued Pot Stocks to Buy?
Yahoo FinanceNov 28 05:50 ET
RBC Capital Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
TipRanksNov 27 20:48 ET · Ratings
Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says
Analyst UpgradesNov 27 13:23 ET

Comments

Meltyy

Nov 26 01:17

🚨 1 PDUFA this week!

See FDA PDUFA update 👇
$Applied Therapeutics (APLT.US)$ : 🤔
⇨ Govorestat
‣ Classic Galactosemia
‣ PDUFA: 11/28/24 (NDA)
🗓️ Last Week’s Adcom & PDUFA decisions:
$BridgeBio Pharma (BBIO.US)$ : Approved 11/22 ✅
⇨Attruby (Acoramidis)
‣ ATTR-CM (transthyretin amyloid cardiomyopathy)
‣ PDUFA: 11/29/24 (NDA)
$AstraZeneca (AZN.US)$ : Discussion, no vote
⇨ Andexxa (coagulation factor Xa)
‣ Life-threatening or uncontrolled bleeding
‣ Adcom: 11/21/24 (sBLA)
$Jazz Pharmaceuticals (JAZZ.US)$ & $Zymeworks (ZYME.US)$ : Approve...

Stock_Drift

Nov 20 18:32

$Jazz Pharmaceuticals (JAZZ.US)$

10xStockPicks

Oct 24 07:55

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable

Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 million Americans take statin drugs, we see continued prescription growth & expect over 5...